Nifurtimox chemotherapy: Collateral effects in treated Trypanosoma cruzi infected patients

Revista Espanola de Quimioterapia

Volumn 25, Issue 1, 2012, Pages 74-75

  Murcia, Laura ^a   Carrilero, Bartolomé ^a   Viñas, Pedro Albajar ^b   Segovia, Manuel ^a,c  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

^c UNIVERSITY OF MURCIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPARASITIC AGENT; BENZNIDAZOLE; CATALASE; GLUTATHIONE; HYDROGEN PEROXIDE; NIFURTIMOX; SUPEROXIDE;

ANOREXIA; ARTHRALGIA; ASTHENIA; CHAGAS DISEASE; CHEMOTHERAPY; DRUG DOSE REDUCTION; DRUG EFFECT; DYSPHAGIA; ENZYME BLOOD LEVEL; ERYTHEMA; HEADACHE; HEART PALPITATION; HUMAN; LETTER; NAUSEA; NEURITIS; NONHUMAN; POLYMERASE CHAIN REACTION; PRURITUS; SIDE EFFECT; SOUTH AND CENTRAL AMERICA; SPAIN; TREMOR; VOMITING; WEIGHT REDUCTION;

CHAGAS DISEASE; HUMANS; NIFURTIMOX; NITROIMIDAZOLES; TRYPANOCIDAL AGENTS; TRYPANOSOMA CRUZI;

EID: 84859652136     PISSN: 02143429     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (8)

1. Gascón J, Bern C, Pinazo MJ. Chagas disease in Spain, the United Stated and other non-endemic countries. Acta Trop 2010; 115: 22-27.
2. Lescure FX, Canestri A, Melliez H, Jauréguiberry S, Develoux M, Dorent R, et al. Chagas disease in France. Emerg Infect Dis 2008; 4: 644-646.
3. Jannin J, Villa L. An overview of Chagas disease treatment. Mem Inst Oswaldo Cruz 2007; 102:(Suppl. I): 95-97.
4. Coura JR. Present situation and new strategies for Chagas disease chemotherapy: a proposal. Mem Inst Oswaldo Cruz 2009; 104: 549-554.
5. The Medical Letter On Drugs and Therapeutics. Drugs For Parasitic Infections. Mark Abramowicz (Editor). New Rochelle (NY): The Medical Letter 2004.
6. a edición Parte 7. Sección 17. Capítulo e17. Farmacología de los antiparasitarios.
7. Carrilero B, Murcia L, Martínez-Lage L, Segovia M. Side effects of benznidazole treatment in a cohort of patients with Chagas disease in non-endemic country. Rev Esp Quimioter 2011; 24:123-126.
8. Murcia L, Carrilero B, Muñoz MJ, Iborra MA, Segovia M. Usefulness of PCR for monitoring benznidazole response in patients with chronic Chagas' disease: a prospective study in a non-disease-endemic country. J Antimicrob Chemother 2010; 65:1759-1764.